1
Return

Eye-Preserving Therapies for Early cT3c Retinoblastoma

delete2026-07-24
delete0
PRE
AI
Z
Zhenyu Xu
Y
Yiran Yao
J
Jie Yang
H
Huihui Wei
Y
Yanping Han
周
周敏 (Min Zhou)
Y
Yitang Liu
Y
Yunhan Zhu
Z
Zining Zhang
R
Reyizha Mengjiang
P
Peiwei Chai
R
Renbing Jia *
范
范先群 (Xianqun Fan) *
X
Xuyang Wen *
范
范佳燕 (Jiayan Fan) *
DOI：10.1016/j.ophtha.2026.07.015delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
To evaluate the safety and effectiveness of eye-preserving therapies in patients with American Joint Committee on Cancer (AJCC) eighth edition cT3c retinoblastoma presenting with neovascular glaucoma (NVG) without buphthalmos (defined as early cT3c), focusing on overall survival and eye preservation.

Journal

Ophthalmology cover
Ophthalmology
IF:
9.5
Papers:
1.3W
Citations:
4.4W

Organization

S
shanghai jiao tong university
Scholars:
15.1W
Papers: 11.5W
Citations: 159
Cited Papers

Cited Papers

Citing Papers

Citing Papers